Form 8-K - Current report:
SEC Accession No. 0001104659-25-011852
Filing Date
2025-02-12
Accepted
2025-02-12 08:06:20
Documents
13
Period of Report
2025-02-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm256232d1_8k.htm   iXBRL 8-K 25165
  Complete submission text file 0001104659-25-011852.txt   196474

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA kala-20250211.xsd EX-101.SCH 3009
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE kala-20250211_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kala-20250211_pre.xml EX-101.PRE 22355
15 EXTRACTED XBRL INSTANCE DOCUMENT tm256232d1_8k_htm.xml XML 3566
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
KALA BIO, Inc. (Filer) CIK: 0001479419 (see all company filings)

EIN.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38150 | Film No.: 25612081
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)